References
- Unsal V, Cicek M, Sabancilar İ. Toxicity of carbon tetrachloride, free radicals and role of antioxidants. Rev Environ Health. 2021;36(2):279–95. doi:https://doi.org/10.1515/reveh-2020-0048.
- Al AASM, Menezes RG. Carbon tetrachloride toxicity. StatPearls. 2021 Feb.
- Teschke R. Liver injury by carbon tetrachloride intoxication in 16 patients treated with forced ventilation to accelerate toxin removal via the lungs: a clinical report. Toxics. 2018;6(2):25. doi:https://doi.org/10.3390/toxics6020025.
- Jan S, Khan MR. Protective effects of monotheca buxifolia fruit on renal toxicity induced by CCl4 in rats. BMC Complement Altern Med. 2016 Aug;16(1). doi:https://doi.org/10.1186/s12906-016-1256-0.
- Habashy NH, Kodous AS, Abu-Serie MM. Targeting ROS/NF-κB signaling pathway by the seedless black Vitis vinifera polyphenols in CCl4-intoxicated kidney, lung, brain, and spleen in rats. Sci Rep. 2021;11(1):1–17. doi:https://doi.org/10.1038/s41598-021-96008-0.
- Hosohata K. Role of oxidative stress in drug-induced kidney injury. Int J Mol Sci. 2016;17:11. doi:https://doi.org/10.3390/ijms17111826.
- Emam NM, Anjum S, Okail HA, Ibrahim MAR, Ahmad T. Pomegranate peel extract protects against carbon tetrachloride-induced nephrotoxicity in mice through increasing antioxidants status. Biomed Rep. 2020;13(3):1–9.
- Lv W, Booz GW, Wang Y, Fan F, Roman RJ. Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol. 2018;820:65–76. doi:https://doi.org/10.1016/j.ejphar.2017.12.016.
- De Vries HS, Van Oijen MGH, Driessen RJB, De Jong EMGJ, Creemers MCW, Kievit W, De Jong DJ. Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists. Br J Clin Pharmacol. 2011;71(1):7–19. doi:https://doi.org/10.1111/j.1365-2125.2010.03760.x.
- Omote K, Gohda T, Murakoshi M, Sasaki Y, Kazuno S, Fujimura T, Ishizaka, M, Sonoda, Y, Tomino, Y . Role of the TNF pathway in the progression of diabetic nephropathy in KK-Ay mice. Am J Physiol - Ren Physiol. 2014 Jun;306(11):F1335–F1347. doi:https://doi.org/10.1152/ajprenal.00509.2013.
- Carlos CP, Sonehara NM, Oliani SM, Burdmann EA. Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat model. PLoS One. 2014 Jul;9(7):e103660. doi:https://doi.org/10.1371/journal.pone.0103660.
- Kirbas A, Cure MC, Kalkan Y, Cure E, Tumkaya L, Sahin OZ, Yuce S, Kizilkaya B, Pergel A. Effect of infliximab on renal injury due to methotrexate in rat. Iran J Kidney Dis 2015;9:221–29.
- Abdelrahman AM, Al Suleimani YM, Manoj P, Ashique M, Ali BH, Schupp N. Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in rats. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(1):121–30. doi:https://doi.org/10.1007/s00210-019-01719-x.
- Pergel A, Tumkaya L, Demiral G, Çolakoğlu MK, Kalcan S, Özdemir A, Mercantepe, T, Erdivanlı, B, Yılmaz, A . The protective effects of Adalimumab on intestinal injury induced with infrarenal aortic occlusion. Ulus Travma Ve Acil Cerrahi Derg 2020;26:366–72.
- Cure E, Kirbas A, Tumkaya L, Cure MC, Şahin OZ, Kalkan Y, Yuce S, Altuner D . Effect of infliximab against cisplatin-induced nephrotoxicity. Saudi Med J 2014;35:953–58.
- Sehitoglu I, Tumkaya L, Bedir R, Ozer E, Cure MC, Kalkan Y, Yuce S, Cure E. Protective effect of infliximab against carbon tetrachloride–induced hepatotoxicity. J Environ Pathol Toxicol Oncol. 2015;34(2):175–82. doi:https://doi.org/10.1615/JEnvironPatholToxicolOncol.2015013126.
- Sung MJ, Kim DH, Jung YJ, Kang KP, Lee AS, Lee S, Kim W, Davaatseren M, Hwang J-T, Kim H-J, et al. Genistein protects the kidney from cisplatin-induced injury. Kidney Int [Internet]. 2008;74(12):1538–47. doi:https://doi.org/10.1038/ki.2008.409.
- Mercantepe F, Mercantepe T, Topcu A, Yılmaz A, Tumkaya L. Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(9):915–31. doi:https://doi.org/10.1007/s00210-018-1514-4.
- Shahbazi F, Dashti-Khavidaki S, Khalili H, Lessan-Pezeshki M. Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature. J Pharm Pharm Sci. 2012;15(1):112–23. doi:https://doi.org/10.18433/J3F88S.
- Ferguson MA, Vaidya VS, Bonventre JV. Biomarkers of nephrotoxic acute kidney injury. Toxicology. 2008;245(3):182–93. 2014. doi:https://doi.org/10.1016/j.tox.2007.12.024.
- Meng XM, Tang PMK, Li J, Lan HY. TGF-ß/Smad signaling in renal fibrosis. Front Physiol. 2015 MAR;6:1–8. doi:https://doi.org/10.3389/fphys.2015.00082.
- Hiromatsu Y, Toda S. Mast cells and angiogenesis. Microsc Res Tech. 2003;60(1):64–69. doi:https://doi.org/10.1002/jemt.10244.
- Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, Jiang , F, Peng, ZY . Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev. 2019;5080843:1–13.
- Lee HS. Mechanisms and consequences of TGF-β overexpression by podocytes in progressive podocyte disease. Cell Tissue Res. 2012;347(1):129–40. doi:https://doi.org/10.1007/s00441-011-1169-7.
- Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6(2):99–104. doi:https://doi.org/10.1038/sj.cdd.4400476.